KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2025)

Hims & Hers Health's Current Deferred Revenue history spans 6 years, with the latest figure at $127.2 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 68.87% year-over-year to $127.2 million; the TTM value through Dec 2025 reached $127.2 million, up 68.87%, while the annual FY2025 figure was $127.2 million, 68.87% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $127.2 million at Hims & Hers Health, up from $118.5 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $127.2 million in Q4 2025 and bottomed at $624000.0 in Q1 2021.
  • The 5-year median for Current Deferred Revenue is $3.8 million (2021), against an average of $31.4 million.
  • The largest annual shift saw Current Deferred Revenue plummeted 53.83% in 2022 before it soared 919.92% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $3.2 million in 2021, then plummeted by 53.83% to $1.5 million in 2022, then skyrocketed by 425.34% to $7.7 million in 2023, then soared by 873.75% to $75.3 million in 2024, then surged by 68.87% to $127.2 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Current Deferred Revenue are $127.2 million (Q4 2025), $118.5 million (Q3 2025), and $98.4 million (Q2 2025).